Rituximab efficacy in pediatric patients with refractory nephrotic syndrome

Background: Nephrotic syndrome (NS) in children is a disease of glomerular filtration barrier failure, manifesting with severe proteinuria leading to hypoalbuminemia, hypercholesterolemia, and generalized edema. it could be primary or secondary. In primary NS, also known as idiopathic NS, the histological findings of Primary NS include minimal change disease which mainly respond to steroids (steroid sensitive NS), focal segmental glomerulosclerosis which are usually steroid resistant or membranous nephropathy. Rituximab has been shown to be effective for patients with complicated FRNS/SDNS and refractory SRNS. While the incidence of nephrotic syndrome (NS) is increasing, the morbidity of difficult-to-treat NS is significant.Methods: This is a retrospective cohort study that took place in King Abdulaziz University Hospital from 2012 to 2016. Patients included: Any patient under 18 years, and diagnosed with steroid resistant and dependent nephrotic syndrome. Patients excluded: Any patient above 18 years, and known to have secondary Nephrotic Syndrome.Results: Present study consists of 24 children with nephrotic syndrome (NS) were recruited in the study. In the population 8 patients (33.33 %) were diagnosed with SDNS, while the other 16 patients (66.67%) were diagnosed SRNS. Also, patients who were treated with Rituximab we found that (the mean) number of relapses per year before rituximab was about 2.67±1.49 (standard deviation 1.49), while patient who relapsed after rituximab was about 1.09±1.38 (standard deviation 1.38).Conclusions: Rituximab is a biological agent that started to be widely used in difficult nephrotic syndrome cases. The effectiveness of rituximab is most observed in steroid depended nephrotic syndrome patients since it decreases the frequency of relapses and steroid dependency. However, it has been shown that it is less effective in steroid resistant nephrotic syndrome cases and was associated with significant numbers of relapses

Allelopathic efficiency of Eruca sativa in controlling two weeds associated with Pisum sativum plants

Allelopathy is a complex phenomenon which depends on allelochemical concentrations. So, two pot experiments were carried out to investigate the allelopathic effect of alcoholic fresh shoot extract of Eruca sativa (foliar spray) and E. sativa shoot powder (mixed with soil) on Pisum sativum plants and two associated weeds, Phalaris minor and Beta vulgaris. The experiments were conducted in the greenhouse of the National Research Centre, Giza, Egypt during two successive winter seasons (2016–2017 and 2017–2018). Ten treatments were applied in this study. Four treatments were applied before sowing, that E. sativa shoot powder was mixed with the soil at rates of 15, 30, 45 and 60 g ⋅ pot–1. The other four treatments of E. sativa alcoholic fresh shoot extract were sprayed twice on both plants and weeds at 5, 10, 15 and 20% (w/v) concentrations. Additionally, two untreated treatments, healthy (P. sativum only) and unweeded (untreated infested P. sativum plants with weeds) were applied for comparison. The results indicated that both alcoholic extracts and powder reduced growth of both weeds. Moreover, there was a direct relationship between concentration and weed reduction. Eruca sativa alcoholic extracts increased yield parameters of P. sativum plants. The maximum yield attributes were recorded by spraying of E. sativa alcoholic extract at 20%. On the other hand, it was clearly noticed that the high powder rates affected negatively P. sativum yield parameters. But the lowest powder rate (15 g ⋅ pot–1) stimulated P. sativum yield parameters as compared to unweeded treatment. Chemical analysis of E. sativa shoot powder ensured that the abundant amount of glucosinolates (9.6 μmol ⋅ g–1) and phenolic compounds (46.5 mg ⋅ g–1) may be responsible for its allelopathic effect. In conclusion, spraying of alcoholic fresh shoot extract of E. sativa at 20% (w/v) and mixing E. sativa shoot powder at 15 g · pot–1can be applied as natural bioherbicides for controlling weeds

UTILIZATION OF SALT WHEY FROM EGYPTIAN RAS (CEPHALOTYRE) CHEESE IN MICROBIAL MILK CLOTTING ENZYMES PRODUCTION

Calf rennet as a traditional milk-clotting enzyme is very important in the production of cheese. The enzyme clots milk and plays an important role in the process of cheese maturation UTILIZATION OF SALT WHEY FROM EGYPTIAN RAS (CEPHALOTYRE) CHEESE IN MICROBIAL MILK CLOTTING ENZYMES PRODUCTION ABSTRACT Background. Microbial milk-clotting enzymes are valued as calf rennet substitutes in the cheese industry. The worldwide increase of cheese production coupled with a reduced supply of calf rennet has prompted a search for calf rennet substitutes, including microbial and plant rennets. However, most plant rennets have proved unsuitable because they impart a bitter taste to the cheese. Microbial rennet appears to be more promising because its production is cheaper, biochemical diversity is greater, and genetic modifi cation is easier. Most cheese manufacturing facilities in Egypt perform land spreading of salt whey. However, this practice increases the chloride levels of soil, and elevates the risk of crop damage. One possible application for salt whey is to use it as a whole medium for growth and production of milk clotting enzyme from fungi. Material and methods. Mucor pusillus QM 436 was identifi ed to produce the highest milk-clotting activity during screening of 19 fungal strains. Salted whey results from Ras (Cephalotyre) cheese manufacture as a whole medium for growth of Mucor pusillus QM 436 and production of the enzyme. Results. The milk-clotting enzyme from Mucor pusillus QM 436 was purifi ed to 7.14-fold with 54.4% recovery by precipitation in ammonium sulfate, ethanol and fractionated by gel fi ltration on Sephadex G-100. The enzyme was active in the pH range 5.5-7.5 and was inactivated completely by heating 5 min at 70°C and 30 min at 65°C. The highest level of enzyme activity was obtained at 60°C, pH 5.5. A positive and proportional relationship occurred in the presence of CaCl 2 in milk, with inhibition which occurred in the presence of NaCl. Conclusions. The high level of milk-clotting activity coupled with a low level of thermal stability suggested that the milk-clotting enzyme from Mucor pusillus QM 436 should be considered as a potential substitute for calf rennet

Assessing chamomile and marjoram meals as feed additives on growth indices and haematological parameters of Nile tilapia (Oreochromis niloticus) reared under biofloc system

First report on using chamomile (Matricaria chamomilla) flower meal [CFM] and marjoram (Origanum majorana) leaves meal [MLM] as dietary supplements in low-protein fish diets on Nile tilapia (Oreochromis niloticus) reared in a bio-floc system. The experiment consisted of 6 groups in triplicates, where the first (T1) and second (T2) groups were fed diets containing 25 and 20% protein, respectively, without any additives. In contrast, the rest of the groups were fed a 20% protein diet, adding CFM at rates of 1% (T3) and 2% (T4) or MLM at rates of 1% (T5) and 2% (T6). The fish were initially weighed 18.44 g ± 0.38 (S.E.) and randomly stocked in 18 experimental tanks at six fingerlings in a water volume of 40 litres (150 fish/m3). Molasses was used as a carbon source with a carbon-to-nitrogen ratio of 16:1 in the treatments fed 20% protein; 12:1 in the treatments provided 25% protein. Feeding was done twice daily, six days a week, at a rate of 3% of body weight for 42 days. Water quality was within the desirable tilapia growth and health limit regarding temperature (23.20 - 24.70 °C), pH (8.43 - 8.65), dissolved oxygen (5.5 - 6.1 mg/L), and NH3 (0.03–0.051 mg/L). Fish fed on a 20% CP diet containing 1% CFM had the highest values in all growth indicators, followed by 2% CFM and 1% MLM then T1 and T2 groups. Blood analysis showed variation (P ≤ 0.05) among groups, and T3 had the highest levels of hemoglobin (Hb), hematocrit (Hct), and red blood cells (RBCs) followed by T5 then T4, T2, while T6 and T1 were the least. In conclusion, using chamomile or marjoram as a feed supplement maximizes the benefits of using the bio-floc system, especially in a lack of water resources and poor protein feeds. Nile tilapia growth and hematological parameters were the best with a 1% chamomile (M. chamomilla) supplement under a biofloc system